Voyager (VOYG) Q3 2026 Earnings Call Transcript

Voyager Technologies reported Q3 2026 revenue of $88.7 million, up 124% year over year, record bookings of $116 million, and backlog of $742 million; it raised FY 2026 revenue guidance to $285 million-$305 million, implying about 78% growth at the midpoint. Total liquidity was $815.7 million, including $553.6 million in cash, while gross margin improved sequentially to 11.5%; adjusted EBITDA was a $44.9 million loss, and management expects full-year gross margins in the low double digits amid capacity investment. Astrobotic contributed $31 million of Q3 revenue and $347 million of acquired backlog, while management cited growing defense demand and Starlab reservations of approximately $700 million.

Analysis

The key underwriting question is not whether demand exists, but whether Voyager can convert it into profitable, cash-generative production. Organic bookings are encouraging, yet the sharp backlog expansion includes acquired Astrobotic work; backlog and Starlab reservations are not equivalent to near-term revenue or cash. Milestone-based lunar programs may absorb working capital and engineering resources well before collections, while the low-double-digit gross-margin outlook and heavy capex leave little room for execution slippage. Pueblo utilization is the hinge: capacity built ahead of awards can defer operating leverage rather than create it.

Near term, Griffin-1 is a binary credibility catalyst: success may improve positioning for follow-on lunar work, while delay or mission failure could impair customer confidence and consume management attention. Over 1–3 months, watch CLPS 2.0 outcomes and any funding delays; NASA’s Starlab decision is a spring 2027 catalyst, not a current revenue driver. Over 6–18 months, the thesis depends on production ramp, backlog conversion, and gross-margin progression. The Anduril relationship could provide a pathway to higher-rate propulsion work, but disclosed collaboration is not proof of future awards. Palantir Technologies, Airbus, and MDA Space are named as Starlab partners; the supplied information does not establish material earnings sensitivity for them.

Contrarian view: the market may over-credit headline growth and reservation totals while underweighting dilution, integration, and cash conversion risk. Conversely, if organic awards convert and utilization rises, current investment drag could mask a genuine margin inflection. Valuation and share-price context are unavailable, so avoid making the earnings beat alone a chase signal.

Key Decisions for Investors

• VOYG: Treat as a catalyst-driven, high-volatility growth position, not a core quality compounder yet. Consider a small, risk-defined starter only after checking valuation and liquidity; add only on evidence of backlog conversion and sustained gross-margin improvement.
• Use Griffin-1 and CLPS 2.0 as near-term decision gates. A successful mission plus additional awards supports the upside case; a material launch delay, mission failure, or weak CLPS result is a reason to reduce exposure.
• Track quarterly organic bookings separately from acquired backlog, revenue recognized versus cash collected, working capital, capex, and gross margin. Falsify the operating-leverage thesis if margins stall while capacity spending remains elevated or management pushes out the path to positive adjusted EBITDA.
• Do not treat approximately $700 million of Starlab reservations as contracted revenue. Reassess after NASA’s spring 2027 award and verify funding, ownership economics, and remaining capital requirements before assigning meaningful value to the project.